[1]黄小琼,陈相才,冯维,等.治疗前ALB/ESR、LDH联合SII对川崎病患儿常规剂量IVIG应答不良的预测价值[J].陕西医学杂志,2025,54(9):1243-1247.[doi:DOI:10.3969/j.issn.1000-7377.2025.09.016]
　HUANG Xiaoqiong,CHEN Xiangcai,FENG Wei,et al.Predictive value of ALB/ESR and LDH combined with SII before treatment for poor response to conventional dose of IVIG in children with Kawasaki disease[J].,2025,54(9):1243-1247.[doi:DOI:10.3969/j.issn.1000-7377.2025.09.016]
点击复制

治疗前ALB/ESR、LDH联合SII对川崎病患儿常规剂量IVIG应答不良的预测价值

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年9期
页码:
1243-1247
栏目:
药物与临床
出版日期:
2025-09-05

文章信息/Info

Title:
Predictive value of ALB/ESR and LDH combined with SII before treatment for poor response to conventional dose of IVIG in children with Kawasaki disease
作者:
黄小琼; 陈相才; 冯维; 孙自国
（川北医学院附属巴中医院 巴中市中心医院儿科，四川 巴中 636000）
Author(s):
HUANG Xiaoqiong; CHEN Xiangcai; FENG Wei; SUN Ziguo
(Department of Pediatrics,Bazhong Hospital Affiliated to North Sichuan Medical College,Bazhong 636000,China)
关键词:
川崎病; 白蛋白与血沉比值; 乳酸脱氢酶; 全身免疫炎症指数; 静脉注射免疫球蛋白; 治疗应答; 相关性
Keywords:
Kawasaki disease; ALB/ESR; LDH; Systemic Immune-Inflammation Index; intravenous immunoglobulin; Treatment response; Correlation
分类号:
R 725.4
DOI:
DOI:10.3969/j.issn.1000-7377.2025.09.016
文献标志码:
A
摘要:
目的：探讨治疗前白蛋白（ALB）与血沉（ESR）比值、乳酸脱氢酶（LDH）联合全身免疫炎症指数（SII）对川崎病患儿静脉注射常规剂量免疫球蛋白（IVIG）应答不良的预测价值。方法：选取接受IVIG治疗的川崎病患儿189例，根据IVIG治疗应答分为敏感组和非敏感组，并按照7∶3比例收集川崎病患儿81例作为数据验证集。比较两组一般资料及治疗前ALB/ESR、LDH、SII水平，采用点二列相关性分析治疗前ALB/ESR、LDH、SII与IVIG治疗应答的相关性，采用受试者工作特征（ROC）曲线分析三项对川崎病患儿常规剂量IVIG应答不良的预测价值，采用Kappa检验分析三项联合预测的结果与数据验证集的一致性。结果：经治疗后评估，189例川崎病患儿中，非敏感组28例，敏感组161例。非敏感组最高体温及LDH、SII高于敏感组，ALB/ESR低于敏感组（均P＜0.05）。治疗前ALB/ESR与IVIG治疗应答呈正相关（r=0.801，P＜0.001），LDH、SII与IVIG治疗应答呈负相关（r=－0.834、－0.875，均P＜0.001）。偏相关分析证实，治疗前ALB/ESR、LDH、SII仍与IVIG治疗应答显著相关（均P＜0.05）。治疗前ALB/ESR、LDH、SII对IVIG治疗应答不良具有一定的预测价值，且三项联合的预测价值高于单项（均P＜0.05）。三项联合预测的结果与数据验证集的一致性较高，Kappa值为0.790，一致性为95.06%（P＜0.05）。结论：治疗前ALB/ESR、LDH、SII与川崎病患儿常规剂量IVIG治疗应答显著相关，对治疗应答不良具有一定的预测效能，三项联合检测能提高预测价值。
Abstract:
Objective:To explore the value of albumin (ALB) to erythrocyte sedimentation rate (ESR) ratio,lactate dehydrogenase (LDH) combined with Systemic Immune-Inflammation Index (SII) before treatment in predicting poor response to conventional dose intravenous immunoglobulin (IVIG) in children with Kawasaki disease.Methods：A total of 189 children with Kawasaki disease who received IVIG treatment were enrolled and divided into sensitive group and non-sensitive group according to the response to IVIG treatment.According to the ratio of 7∶3,81 children with Kawasaki disease were collected as the data validation set.The general data and the levels of ALB/ESR,LDH and SII before treatment were compared between the two groups,and the correlation between ALB/ESR,LDH,SII before treatment and the response to IVIG treatment was analyzed point-biserial correlation analysis.ROC curve was used to analyze the predictive value of three indexes for poor response to conventional dose of IVIG in children with Kawasaki disease.Kappa test was used to analyze the consistency between the results of the three joint predictions and the data validation set.Results:By evaluation after treatment,among 189 children with Kawasaki disease,28 were in the non-sensitive group and 161 were in the sensitive group.The maximum body temperature,LDH and SII in the non-sensitive group were higher than those in the sensitive group,and the ALB/ESR was lower than that in the sensitive group (all P<0.05).ALB/ESR before treatment was positively correlated with IVIG treatment response (r=0.801,P<0.001),LDH and SII were negatively correlated with IVIG treatment response (r=－0.834,－0.875,both P<0.001).Partial correlation analysis confirmed that ALB/ESR,LDH and SII before treatment were still significantly correlated with IVIG treatment response (all P<0.05).ALB/ESR,LDH and SII before treatment had certain predictive value for poor response to IVIG treatment,and the predictive value of the combination of the three was higher than that of each single item (all P<0.05).The results of the three joint predictions were highly consistent with the data validation set,with a Kappa value of 0.790 and a consistency of 95.06% (P<0.05).Conclusion:ALB/ESR,LDH and SII before treatment are significantly correlated with the response to conventional dose IVIG treatment in children with Kawasaki disease,and they have certain predictive values for poor response to IVIG treatment,and the combined detection of the three indicators can improve the predictive value.

参考文献/References:

[1]黄玉娟,李夙凌,田园,等.中国儿童川崎病诊疗循证指南（2023年）[J].中国当代儿科杂志,2023,25(12):1198-1210.
[2]JONE P N,TREMOULET A,CHOUEITER N,et al.Update on diagnosis and management of kawasaki disease:A scientific statement from the american heart association[J].Circulation,2024,150(23):e481-e500.
[3]雷文娟,周奇,高琲,等.静脉注射免疫球蛋白治疗儿童川崎病的循证指南（2023）[J].兰州大学学报(医学版),2024,50(1):52-60,81.
[4]CONTI F,MORATTI M,LEONARDI L,et al.Anti-inflammatory and immunomodulatory effect of high-dose immunoglobulins in children:From approved indications to off-label use[J].Cells,2023,12(19):2417.
[5]张伊月,范晓晨.血钠联合血白蛋白水平在川崎病患儿临床评估中的价值[J].中国临床研究,2023,36(4):605-609.
[6]张玉坤,黄春华,杨蕾,等.血清白蛋白、血沉、血小板/淋巴细胞比值、中性粒细胞/淋巴细胞比值与川崎病患儿冠脉病变程度的关系[J].中国医师杂志,2023,25(1):23-27.
[7]许莉莉,朱丽娟.中性粒细胞表面CD64表达结合心肌酶学诊断小儿川崎病并心肌损伤的临床研究[J].中国妇幼健康研究,2022,33(8):53-58.
[8]HUANG H,JIANG J,SHI X,et al.Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with kawasaki disease in eastern China[J].Ann Med,2022,54(1):442-453.
[9]赵陆华,徐厚娥.NLR与SII对川崎病患儿并发冠状动脉病变的诊断价值分析[J].中华全科医师杂志,2024,23(3):285-289.
[10]中华医学会儿科学分会心血管学组,中华医学会儿科学分会风湿学组,中华医学会儿科学分会免疫学组,等.川崎病诊断和急性期治疗专家共识[J].中华儿科杂志,2022,60(1):6-13.
[11]杨敏,刘鑫.血清可溶性肿瘤坏死因子受体Ⅱ/Ⅰ比值、白细胞介素-17联合心电图诊断川崎病患儿急性期冠状动脉损伤的价值[J].陕西医学杂志,2025,54(3):338-342.
[12]冯千伟,王晓青,焦丽华,等.川崎病患儿血清血管生成素样蛋白8、生长分化因子-15水平与并发冠状动脉病变关系研究[J].陕西医学杂志,2025,54(3):364-368.
[13]刘杰.解毒化瘀汤联合丙种球蛋白治疗川崎病临床观察[J].陕西中医,2017,38(2):180-181.
[14]李立明,程庆春,王琨.川崎病临床误诊分析及防范措施[J].临床误诊误治,2023,36(10):22-26.
[15]LIU J,CHEN X,YANG M,et al.C-reactive protein to albumin ratio as a prognostic tool for predicting intravenous immunoglobulin resistance in children with kawasaki disease:A systematic review of cohort studies[J].Pediatr Rheumatol Online J,2024,22(1):42.
[16]吴丽平,青秀,李刚,等.低密度脂蛋白胆固醇对川崎病患儿丙种球蛋白耐药的预测价值[J].实用医院临床杂志,2022,19(2):65-68.
[17]王智海.NF-κB、PAI-1、血沉在川崎病并发冠状动脉损伤诊断及病情评估中的应用价值[J].河北医学,2022,28(4):594-599.
[18]LIU J,YE B,SU D,et al.Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in kawasaki disease before and after therapy[J].Clin Rheumatol,2023,42(1):167-177.
[19]ZHANG J,HUANG H,XU L,et al.Knowledge framework of intravenous immunoglobulin resistance in the field of kawasaki disease:A bibliometric analysis (1997-2023)[J].Immun Inflamm Dis,2024,12(5):e1277.
[20]ZAHARI N,BAH M N M,SULIEMAN M F,et al.Intravenous immunoglobulin-resistant kawasaki disease:Risk factors in children in a middle-income country[J].Ann Pediatr Cardiol,2023,16(2):102-108.
[21]李靖,李丹,周萍,等.川崎病患儿心肌酶相关指标、IL-6、BNP与冠状动脉Z值的关系及对冠状动脉病变的预测价值[J].国际检验医学杂志,2023,44(23):2902-2908,2913.
[22]WANG J,HUANG X,GUO D.Predictors and a novel predictive model for intravascular immunoglobulin resistance in Kawasaki disease[J].Ital J Pediatr,2023,49(1):126.
[23]XIE T,WANG Y,FU S,et al.Predictors for intravenous immunoglobulin resistance and coronary artery lesions in kawasaki disease[J].Pediatr Rheumatol Online J,2017,15(1):17.
[24]HUANG T,PENG Q,ZHANG Y,et al.The Systemic Immune-Inflammation Index (SII) and coronary artery lesions in kawasaki disease[J].Clin Exp Med,2024,24(1):4.
[25]储安贞,张兰.系统免疫炎症指数在川崎病IVIG治疗抵抗患儿中的预测价值[J].中华全科医学,2022,20(11):1884-1888.

相似文献/References:

[1]孙春晖,乐 原.川崎病合并冠状动脉病变患儿前白蛋白、胱抑素C、血小板四项变化及临床意义[J].陕西医学杂志,2021,50(12):1573.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.027]
　SUN Chunhui,LE Yuan.Changes and clinical significance of prealbumin,cystatin C and four parameters of platelet in Kawasaki disease children with coronary arterial lesions[J].,2021,50(9):1573.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.027]
[2]严晓华,王 娜,马 娟,等.阿托伐他汀对小鼠川崎病的治疗作用及机制研究[J].陕西医学杂志,2022,51(6):672.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.007]
　YAN Xiaohua,WANG Na,MA Juan,et al.Therapeutic effect and mechanism of atorvastatin on Kawasaki disease mice[J].,2022,51(9):672.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.007]
[3]寇志军,李 静,马亨曼,等.川崎病患儿心血管病变易感性与血清N末端B型脑钠肽原、前白蛋白及C-反应蛋白表达水平相关性研究[J].陕西医学杂志,2022,51(6):717.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.018]
　KOU Zhijun,LI Jing,MA Hengman,et al.Correlation between cardiovascular disease susceptibility and serum levels of NT-proBNP,PA and CRP in children with Kawasaki disease[J].,2022,51(9):717.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.018]
[4]赵 萌,杨轶童,李翰文,等.肠道微生物菌群与川崎病关系研究进展[J].陕西医学杂志,2024,(2):270.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.027]
　ZHAO Meng,YANG Yitong,LI Hanwen,et al.Research progress on relationship between gut microbiota and Kawasaki disease[J].,2024,(9):270.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.027]
[5]杨 敏,刘 鑫.血清可溶性肿瘤坏死因子受体Ⅱ/Ⅰ比值、白细胞介素-17联合心电图诊断川崎病患儿急性期冠状动脉损伤的价值[J].陕西医学杂志,2025,54(3):338.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.010]
　YANG Min,LIU Xin.Value of serum sTNFR Ⅱ/Ⅰ,IL-17 combined with ECG in diagnosis of coronary artery injury in children with Kawasaki disease in acute phase[J].,2025,54(9):338.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.010]
[6]冯千伟,王晓青,焦丽华,等.川崎病患儿血清血管生成素样蛋白8、生长分化因子-15水平与并发冠状动脉病变关系研究[J].陕西医学杂志,2025,54(3):364.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.015]
　FENG Qianwei,WANG Xiaoqing,JIAO Lihua,et al.Relationship between serum ANGPTL8,GDF-15 levels with concurrent coronary artery disease in children with Kawasaki disease[J].,2025,54(9):364.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.015]
[7]严晓华,张泰鸣,高娜,等.超声心动图冠状动脉Z值在川崎病患儿治疗前后的变化及其预测因素分析[J].陕西医学杂志,2025,54(12):1641.[doi:DOI:10.3969/j.issn.1000-7377.2025.12.009]
　YAN Xiaohua,ZHANG Taiming,GAO Na,et al.Changes in echocardiographic coronary artery Z-scores before and after treatment in children with Kawasaki disease and its predictors[J].,2025,54(9):1641.[doi:DOI:10.3969/j.issn.1000-7377.2025.12.009]

备注/Memo

备注/Memo:
四川省医学（青年创新）科研课题（S19227）
更新日期/Last Update: 2025-09-04